Diploma PLC (LON:DPLM - Get Free Report)'s stock price hit a new 52-week high during trading on Thursday after Berenberg Bank raised their price target on the stock from GBX 5,750 to GBX 6,350. Berenberg Bank currently has a buy rating on the stock. Diploma traded as high as GBX 5,565 ($75.70) and last traded at GBX 5,540 ($75.36), with a volume of 239194 shares trading hands. The stock had previously closed at GBX 5,440 ($74.00).
DPLM has been the subject of a number of other reports. JPMorgan Chase & Co. restated a "neutral" rating and set a GBX 4,440 target price on shares of Diploma in a report on Wednesday, August 6th. Jefferies Financial Group raised their target price on shares of Diploma from GBX 4,500 to GBX 5,200 and gave the stock a "hold" rating in a report on Thursday, September 11th. Finally, Shore Capital restated a "hold" rating and set a GBX 5,100 target price on shares of Diploma in a report on Thursday, July 17th. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, Diploma currently has a consensus rating of "Hold" and a consensus target price of GBX 5,238.
Check Out Our Latest Stock Analysis on Diploma
Diploma Trading Down 0.9%
The firm has a market capitalization of £7.31 billion, a P/E ratio of 4,385.43, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The business's 50-day moving average is GBX 5,299.66 and its 200 day moving average is GBX 4,632.25. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.